ERBB2 and invasive ductal breast carcinoma: Additionally, poor overall survival was associated with HER2-negative tumors, HER2-positive tumors, ER-negative tumors, ER-positive tumors, PR-negative tumors, PR-positive tumors, infiltrating ductal carcinoma and infiltrating lobular carcinoma.